DEFINITIVE PROXY

Company

Theriva Biologics, Inc.

Filed

May 21, 1996

Period of Report

June 20, 1996

Accession Number

0000921895-96-000170

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →